Literature DB >> 1570553

Treatment of acute rejection.

D H Adams1, J M Neuberger.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1570553     DOI: 10.1055/s-2007-1007379

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  10 in total

1.  Hepatobiliary Quiz (Answers)-15 (2015).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2015-10-27

2.  Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: immunosuppressive effects after in vivo administration to rats.

Authors:  R Mehvar; D A Hoganson
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

3.  Defective interleukin-1 receptor antagonist production is associated with resistance of acute liver graft rejection to steroid therapy.

Authors:  F Conti; S Breton; F Batteux; V Furlan; D Houssin; B Weill; Y Calmus
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

Review 4.  Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis.

Authors:  Andreas Pascher; Maxim Nebrig; Peter Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2013-03-08       Impact factor: 5.594

5.  Plasma pharmacokinetics and tissue disposition of novel dextran-methylprednisolone conjugates with peptide linkers in rats.

Authors:  Suman Penugonda; Hitesh K Agarwal; Keykavous Parang; Reza Mehvar
Journal:  J Pharm Sci       Date:  2010-03       Impact factor: 3.534

6.  Attenuation of acute rejection in a rat liver transplantation model by a liver-targeted dextran prodrug of methylprednisolone.

Authors:  Anjaneya P Chimalakonda; Donald L Montgomery; Jon A Weidanz; Imam H Shaik; Justin H Nguyen; John J Lemasters; Eiji Kobayashi; Reza Mehvar
Journal:  Transplantation       Date:  2006-03-15       Impact factor: 4.939

7.  Attenuation of Kupffer cell activation in cold-preserved livers after pretreatment of rats with methylprednisolone or its macromolecular prodrug.

Authors:  Anjaneya P Chimalakonda; Reza Mehvar
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

Review 8.  Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients.

Authors:  Luit Penninga; André Wettergren; Colin H Wilson; An-Wen Chan; Daniel A Steinbrüchel; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2014-06-05

9.  Liver Allograft Failure After Nivolumab Treatment-A Case Report With Systematic Literature Research.

Authors:  Dimitri Gassmann; Stefan Weiler; Joachim C Mertens; Cäcilia S Reiner; Bart Vrugt; Mirjam Nägeli; Joanna Mangana; Beat Müllhaupt; Fabienne Jenni; Benjamin Misselwitz
Journal:  Transplant Direct       Date:  2018-07-20

Review 10.  Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons.

Authors:  Yi Luo; Fei Teng; Hong Fu; Guo-Shan Ding
Journal:  World J Gastrointest Oncol       Date:  2022-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.